Abstract

Comparative genomic hybridization (CGH) is a DNA-based technique that allows screening of the entire genome or individual chromosomes for the detection and location of chromosomal losses and gains. It accomplishes this without the need for cell culture and can therefore be employed on a wide range of routinely available specimens including fresh tissue and cell preparations, frozen tissue and formalin-fixed paraffin-embedded (FFPE) tissue. Therefore, large numbers of formalin-fixed tumours can be screened. This may then provide data regarding chromosomal gains and losses as both diagnostic tools and as markers of tumour progression. More specific investigation of the chromosomes can then be carried out by additional techniques such as fluorescent in situ hybridization, loss of heterozygosity analysis or DNA sequencing. CGH, however, is a difficult technique to perform and this is further confounded by the use of FFPE material. We describe some of the problems associated with using paraffin-embedded tissue as a source of DNA for use in CGH.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.